Nxera Pharma Co Ltd (FRA:JSS)
€ 7.1 0 (0%) Market Cap: 655.04 Mil Enterprise Value: 777.64 Mil PE Ratio: 0 PB Ratio: 1.56 GF Score: 65/100

Sosei Group Corp at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 14, 2021 / 03:00PM GMT
Release Date Price: €15.1 (+0.67%)
Seiji Wakao
JPMorgan Chase & Co, Research Division - VP

Good morning, everyone. Welcome to the JPMorgan Healthcare Conference. I'm Seiji Wakao, Japan pharma analyst in JPMorgan. And it's my pleasure to introduce Chris Cargill, CFO with Sosei; and Miles Congreve, Chief Scientific Officer, will join for Q&A session. Welcome them to the conference. (Operator Instructions)

With that, let me turn it over to Chris. Please go ahead. Chris?

Chris Cargill
Sosei Group Corporation - Group COO & CFO

Thank you very much, Wakao-san. I'm beginning on the cover page. And good morning, and welcome to the Sosei Heptares presentation at the 39th Annual JPMorgan Healthcare Conference. Despite the COVID environment, it's wonderful to be able to present virtually. I'd like to thank our friends again at JPMorgan for their continued support and for inviting us to present back again this year.

This morning, I'm going to give you a brief overview of our drug discovery platform and core capabilities. In addition to updating on the excellent progress that

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot